CorMedix Inc
CRMD7.690USD
+0.340+4.63%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
602.50M시가총액
3.24P/E TTM
자세한 내용은 CorMedix Inc 회사
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.
CorMedix Inc 정보
종목 코드 CRMD
회사 이름CorMedix Inc
상장일Mar 25, 2010
CEOTodisco (Joseph)
직원 수64
유형Ordinary Share
회계 연도 종료Mar 25
주소300 Connell Drive
도시BERKELEY HEIGHTS
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호07922
전화19085179500
웹사이트https://cormedix.com/
종목 코드 CRMD
상장일Mar 25, 2010
CEOTodisco (Joseph)
CorMedix Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
490.30K
+188097.00%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
133.10K
+45453.00%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer
Chief Financial Officer
132.74K
+63053.00%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
43.93K
+20453.00%
Mr. Gregory Scott (Greg) Duncan
Mr. Gregory Scott (Greg) Duncan
Independent Director
Independent Director
43.79K
+30453.00%
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
41.45K
+30453.00%
Mr. Dan Ferry
Mr. Dan Ferry
IR Contact Officer
IR Contact Officer
--
--
Ms. Erin Mistry
Ms. Erin Mistry
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
--
--
Ms. Beth Zelnick Kaufman
Ms. Beth Zelnick Kaufman
Executive Vice President, Chief Legal and Compliance Officer, Corporate Secretary
Executive Vice President, Chief Legal and Compliance Officer, Corporate Secretary
--
--
Mr. Myron M. Kaplan, J.D.
Mr. Myron M. Kaplan, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
490.30K
+188097.00%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
133.10K
+45453.00%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer
Chief Financial Officer
132.74K
+63053.00%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
43.93K
+20453.00%
Mr. Gregory Scott (Greg) Duncan
Mr. Gregory Scott (Greg) Duncan
Independent Director
Independent Director
43.79K
+30453.00%
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
41.45K
+30453.00%
수익 분석
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States
104.28M
0.00%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Thu, Jan 29
마지막 업데이트: Thu, Jan 29
주주
주주 유형
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
6.40%
Deep Track Capital LP
6.29%
Abdalkader (Shaibatalhamd Aymen)
5.84%
The Vanguard Group, Inc.
5.69%
Marshall Wace LLP
4.41%
기타
71.37%
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
6.40%
Deep Track Capital LP
6.29%
Abdalkader (Shaibatalhamd Aymen)
5.84%
The Vanguard Group, Inc.
5.69%
Marshall Wace LLP
4.41%
기타
71.37%
주주 유형
주주
비율
Investment Advisor
27.91%
Hedge Fund
16.86%
Investment Advisor/Hedge Fund
15.44%
Individual Investor
7.82%
Research Firm
2.04%
Pension Fund
1.11%
Bank and Trust
0.32%
Insurance Company
0.03%
Venture Capital
0.03%
기타
28.44%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
338
43.86M
55.93%
+10.78K
2025Q3
340
43.85M
56.33%
+8.67M
2025Q2
304
34.76M
43.08%
+9.67M
2025Q1
267
24.95M
43.35%
-4.41M
2024Q4
241
23.99M
39.87%
+4.76M
2024Q3
216
19.17M
36.31%
+1.94M
2024Q2
207
17.23M
38.40%
-272.84K
2024Q1
207
17.37M
41.54%
-5.46M
2023Q4
207
18.82M
39.64%
+838.41K
2023Q3
199
17.96M
39.30%
-1.31M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
5.04M
6.4%
+248.22K
+5.18%
Sep 30, 2025
Deep Track Capital LP
4.96M
6.29%
+4.46M
+891.10%
Nov 21, 2025
Abdalkader (Shaibatalhamd Aymen)
4.65M
6.22%
+4.65M
--
Aug 08, 2025
The Vanguard Group, Inc.
3.96M
5.03%
-347.89K
-8.07%
Sep 30, 2025
Marshall Wace LLP
3.47M
4.41%
+893.52K
+34.63%
Sep 30, 2025
Deerfield Management Company, L.P.
3.32M
4.22%
+3.32M
--
Sep 30, 2025
State Street Investment Management (US)
1.84M
2.33%
+233.97K
+14.61%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.81M
2.3%
+213.45K
+13.37%
Sep 30, 2025
Citadel Advisors LLC
1.72M
2.18%
+2.87K
+0.17%
Sep 30, 2025
Alyeska Investment Group, L.P.
1.26M
1.6%
+512.98K
+68.40%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
State Street SPDR S&P Pharmaceuticals ETF
2.01%
Invesco Biotechnology & Genome ETF
1.87%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.52%
VictoryShares Small Cap Free Cash Flow ETF
0.79%
First Trust Active Factor Small Cap ETF
0.3%
Janus Henderson Small Cap Growth Alpha ETF
0.25%
ALPS Barron's 400 ETF
0.21%
Janus Henderson Small/Mid Cap Growth Alpha ETF
0.19%
Vanguard US Multifactor ETF
0.16%
iShares Micro-Cap ETF
0.15%
더 보기
State Street SPDR S&P Pharmaceuticals ETF
비율2.01%
Invesco Biotechnology & Genome ETF
비율1.87%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
비율1.52%
VictoryShares Small Cap Free Cash Flow ETF
비율0.79%
First Trust Active Factor Small Cap ETF
비율0.3%
Janus Henderson Small Cap Growth Alpha ETF
비율0.25%
ALPS Barron's 400 ETF
비율0.21%
Janus Henderson Small/Mid Cap Growth Alpha ETF
비율0.19%
Vanguard US Multifactor ETF
비율0.16%
iShares Micro-Cap ETF
비율0.15%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
